Vistin Pharma ASA (VISTN) — Cash Flow Quality Index
Vistin Pharma ASA (VISTN) has a Cash Flow Quality Index of 0.34x as of June 2025. Operating cash flow of Nkr6.37 Million is below net income of Nkr18.47 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Vistin Pharma ASA cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Vistin Pharma ASA Cash Flow Quality Index (2016–2024)
Historical Cash Flow Quality Index for Vistin Pharma ASA across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Vistin Pharma ASA total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Vistin Pharma ASA (2016–2024)
Year-by-year earnings quality comparison for Vistin Pharma ASA. For live market cap and the full company financial profile, see Vistin Pharma ASA stock valuation.
| Year | Quality Index | Operating CF (NOK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.34x | Nkr107.86 Million | Nkr80.45 Million | ▼ -13.4% |
| 2023 | 1.55x | Nkr90.59 Million | Nkr58.52 Million | ▲ +181.4% |
| 2021 | 0.55x | Nkr13.68 Million | Nkr24.87 Million | ▲ +92.4% |
| 2019 | 0.29x | Nkr18.93 Million | Nkr66.20 Million | ▲ +111.8% |
| 2017 | 0.14x | Nkr9.51 Million | Nkr70.40 Million | ▼ -96.8% |
| 2016 | 4.17x | Nkr53.84 Million | Nkr12.92 Million | — |